Sall4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1 - PubMed (original) (raw)
. 2006 Oct;8(10):1114-23.
doi: 10.1038/ncb1481. Epub 2006 Sep 17.
Wai-Leong Tam, Guo Qing Tong, Qiang Wu, Hsiao-Yun Chan, Boon-Seng Soh, Yuefei Lou, Jianchang Yang, Yupo Ma, Li Chai, Huck-Hui Ng, Thomas Lufkin, Paul Robson, Bing Lim
Affiliations
- PMID: 16980957
- DOI: 10.1038/ncb1481
Sall4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1
Jinqiu Zhang et al. Nat Cell Biol. 2006 Oct.
Abstract
Embryonic stem (ES) cells are pluripotent cells that can self-renew or differentiate into many cell types. A unique network of transcription factors and signalling molecules are essential for maintaining this capability. Here, we report that a spalt family member, Sall4, is required for the pluripotency of ES cells. Similarly to Oct4, a reduction in Sall4 levels in mouse ES cells results in respecification, under the appropriate culture conditions, of ES cells to the trophoblast lineage. Sall4 regulates transcription of Pou5f1 which encodes Oct4. Sall4 binds to the highly conserved regulatory region of the Pou5f1 distal enhancer and activates Pou5f1 expression in vivo and in vitro. Microinjection of Sall4 small interfering (si) RNA into mouse zygotes resulted in reduction of Sall4 and Oct4 mRNAs in preimplantation embryos and significant expansion of Cdx2 expression into the inner cell mass. These results demonstrate that Sall4 is a transcriptional activator of Pou5f1 and has a critical role in the maintenance of ES cell pluripotency by modulating Oct4 expression. The data also indicates that Sall4 is important for early embryonic cell-fate decisions.
Similar articles
- Yamanaka factors critically regulate the developmental signaling network in mouse embryonic stem cells.
Liu X, Huang J, Chen T, Wang Y, Xin S, Li J, Pei G, Kang J. Liu X, et al. Cell Res. 2008 Dec;18(12):1177-89. doi: 10.1038/cr.2008.309. Cell Res. 2008. PMID: 19030024 - Pluripotent lineage definition in bovine embryos by Oct4 transcript localization.
Kurosaka S, Eckardt S, McLaughlin KJ. Kurosaka S, et al. Biol Reprod. 2004 Nov;71(5):1578-82. doi: 10.1095/biolreprod.104.029322. Epub 2004 Jun 30. Biol Reprod. 2004. PMID: 15229144 - Oct4 expression revisited: potential pitfalls for data misinterpretation in stem cell research.
Liedtke S, Stephan M, Kögler G. Liedtke S, et al. Biol Chem. 2008 Jul;389(7):845-50. doi: 10.1515/BC.2008.098. Biol Chem. 2008. PMID: 18627312 Review. - How is pluripotency determined and maintained?
Niwa H. Niwa H. Development. 2007 Feb;134(4):635-46. doi: 10.1242/dev.02787. Epub 2007 Jan 10. Development. 2007. PMID: 17215298 Review.
Cited by
- Sall4 and Gata4 induce cardiac fibroblast transition towards a partially multipotent state with cardiogenic potential.
Gao H, Pathan S, Dixon BREA, Pugazenthi A, Mathison M, Mohamed TMA, Rosengart TK, Yang J. Gao H, et al. Sci Rep. 2024 Oct 15;14(1):24182. doi: 10.1038/s41598-024-73975-8. Sci Rep. 2024. PMID: 39406776 Free PMC article. - Endogenous retroviral ERVH48-1 promotes human urine cell reprogramming.
Peng Y, Zhu J, Zhang Q, Zhang R, Wang Z, Ye Z, Ma N, Qin D, Pei D, Li D. Peng Y, et al. Cell Regen. 2024 Sep 13;13(1):17. doi: 10.1186/s13619-024-00200-2. Cell Regen. 2024. PMID: 39269631 Free PMC article. - Cell fate decision by a morphogen-transcription factor-chromatin modifier axis.
Ming J, Lin L, Li J, Wu L, Fang S, Huang T, Fu Y, Liu D, Zhang W, Li C, Yang Y, Huang Y, Qin Y, Kuang J, Huang X, Guo L, Zhang X, Liu J, Chen J, Zhao C, Wang B, Pei D. Ming J, et al. Nat Commun. 2024 Jul 29;15(1):6365. doi: 10.1038/s41467-024-50144-z. Nat Commun. 2024. PMID: 39075094 Free PMC article. - Sall4 regulates downstream patterning genes during limb regeneration.
Erickson JR, Walker SE, Arenas Gomez CM, Echeverri K. Erickson JR, et al. Dev Biol. 2024 Nov;515:151-159. doi: 10.1016/j.ydbio.2024.07.015. Epub 2024 Jul 25. Dev Biol. 2024. PMID: 39067503 - Cancer stem cells: advances in knowledge and implications for cancer therapy.
Chu X, Tian W, Ning J, Xiao G, Zhou Y, Wang Z, Zhai Z, Tanzhu G, Yang J, Zhou R. Chu X, et al. Signal Transduct Target Ther. 2024 Jul 5;9(1):170. doi: 10.1038/s41392-024-01851-y. Signal Transduct Target Ther. 2024. PMID: 38965243 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
- AI54973/AI/NIAID NIH HHS/United States
- DK04763/DK/NIDDK NIH HHS/United States
- K08 CA097185/CA/NCI NIH HHS/United States
- K08 DK063220/DK/NIDDK NIH HHS/United States
- P20 RR016464/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases